Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

This medication is an angiotensin-converting enzyme (ACE) inhibitor, prescribed for high blood pressure. This medication is an angiotensin-converting enzyme inhibitor (ACE inhibitor), prescribed ...

The efficacy of both ACE inhibitors and ARBs as antihypertensive agents is well documented. [1,36] When compared head-to-head, ACE inhibitors and ARBs reduce BP comparably. [1] In ...

ACE inhibitors keep the body from making a hormone called angiotensin II, which causes blood vessels to narrow. These medications lower blood pressure by helping constricted blood vessels expand ...

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific ...

The use of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in people with congestive heart failure (CHF) and renal dysfunction is poorly studied.

Off-label uses outside of the drug's formal Food and Drug Administration (FDA) approval can include migraines and other health issues. Researchers continue to investigate ACE inhibitor use in treating ...

Angiotensin II receptor antagonists (A II) are another promising alternative therapy for patients who cannot use ACE inhibitors. Current clinical trials will help clarify the role of these drugs ...